RHAELM OPERATIONS LIMITED

Company number 17001530 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score

Grade: Not assessable — no A–F grade can be assigned.

Rhaelm Operations Limited was incorporated on 30 January 2026 and has not yet filed any annual accounts. The first accounts are not due until 30 September 2027. Because there is no balance sheet, profit and loss account, or cash flow statement, there are no financial vital signs to measure or grade. A provisional structural assessment would place the company in a high-risk, early-incubation category, but this is not a financial health score.


Key Vital Signs

Indicator Reading Interpretation
Company status Active The company is registered and not in liquidation, administration, or receivership.
Incorporation date 30 January 2026 Very recently formed; comparable to a newborn patient with no medical history.
Share capital £1.00 Minimal capitalisation; provides almost no financial buffer against losses or shocks.
Accounts filing Up to date; next due 30 September 2027 No overdue filings, equivalent to taking prescribed medication on schedule.
Confirmation statement Up to date; next due 12 February 2027 Compliance with administrative obligations is currently stable.
Business activity SIC 82990 – Other business support service activities No financial performance data available for this sector classification.
Persons with significant control Two corporate entities, each recorded as holding >75% of shares and voting rights Concentrated ownership; the dual >75% positions warrant clarification with Companies House.
Recent name change From Sovereign AI Operations Limited on 27 August 2026 Early rebranding; may be routine or may signal restructuring.
Officer changes One director resigned on 10 July 2026 Early board movement; without accounts, it is impossible to tell whether this is routine or distress-related.

Symptoms Analysis

  • No financial pulse: There are no figures for turnover, profit, assets, liabilities, or cash. It is not possible to assess solvency, liquidity, or working capital.
  • Thin capitalisation: A share capital of £1 offers no loss-absorbing capacity. If the company begins trading and incurs even modest losses, it could quickly become technically insolvent without additional funding.
  • Early governance movements: A name change and a director resignation within the first months of incorporation can be normal for a startup finding its shape, but they can also be early symptoms of strategic instability. Without filed accounts, there is no way to determine whether these changes are financially motivated.
  • Ownership concentration: The PSC register lists two separate corporate entities each holding more than 75% of shares and voting rights. Mathematically, two distinct shareholders cannot each hold more than 75% of the same company unless they are part of the same group or the register entries overlap. This should be clarified rather than ignored.
  • Compliance vital signs are stable: No accounts or confirmation statements are overdue. This is a positive administrative sign, though it says nothing about trading performance.

Diagnosis

Financial health is indeterminate. The company is legally active and administratively compliant, but it is economically unaudited. In medical terms, the patient is conscious and responsive, but no blood tests have yet been taken. There is no evidence of insolvency, liquidation, or administration. However, with only £1 of share capital and no filed trading history, the company has no measurable financial reserves and no track record of generating cash.


Prognosis

Guarded, but not critical. The outlook depends on whether the company:

  1. Commences trading and generates revenue before its first accounts fall due;
  2. Strengthens its capital base to absorb early losses; and
  3. Maintains its filing schedule to avoid penalties or eventual strike-off.

If no trading activity or accounts emerge by September 2027, the risk of administrative failure increases. If the company trades successfully, builds cash reserves, and files on time, the prognosis improves significantly.


Recommendations

  1. Prepare the first accounts early. Do not wait until the September 2027 deadline. Draft management accounts now to monitor cash burn and trading performance.
  2. Review share capital. Consider increasing the nominal share capital above £1 to provide a credible buffer and improve standing with suppliers, landlords, or lenders.
  3. Clarify the PSC register. Confirm how two corporate entities can each hold more than 75% of shares and voting rights, and file any necessary corrections with Companies House.
  4. Maintain compliance. File the confirmation statement by 12 February 2027 and the first accounts by 30 September 2027 to avoid late-filing penalties.
  5. Establish financial controls. Once trading begins, track a current ratio (current assets divided by current liabilities), cash runway, and debtor payment terms to spot liquidity stress early.
  6. Seek professional advice. Register for the appropriate taxes (corporation tax, VAT if applicable, and PAYE if employing staff) and agree suitable accounting policies with an accountant.

Perspective: Financial Health Diagnostician · Model: nvidia/nemotron-3.5-super-vl:free · Generated 14 November 2026